Logo image of DRW3.DE

DRAEGERWERK AG - PREF (DRW3.DE) Stock Fundamental Analysis

Europe - FRA:DRW3 - DE0005550636

67.2 EUR
0 (0%)
Last: 9/12/2025, 4:25:58 PM
Fundamental Rating

5

Taking everything into account, DRW3 scores 5 out of 10 in our fundamental rating. DRW3 was compared to 59 industry peers in the Health Care Equipment & Supplies industry. DRW3 has an average financial health and profitability rating. DRW3 is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year DRW3 was profitable.
In the past year DRW3 had a positive cash flow from operations.
DRW3 had positive earnings in 4 of the past 5 years.
DRW3 had a positive operating cash flow in 4 of the past 5 years.
DRW3.DE Yearly Net Income VS EBIT VS OCF VS FCFDRW3.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of 3.34%, DRW3 is in line with its industry, outperforming 50.00% of the companies in the same industry.
DRW3 has a Return On Equity (6.82%) which is comparable to the rest of the industry.
The Return On Invested Capital of DRW3 (6.55%) is better than 62.07% of its industry peers.
Industry RankSector Rank
ROA 3.34%
ROE 6.82%
ROIC 6.55%
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
DRW3.DE Yearly ROA, ROE, ROICDRW3.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

DRW3 has a Profit Margin (2.97%) which is in line with its industry peers.
In the last couple of years the Profit Margin of DRW3 has grown nicely.
DRW3's Operating Margin of 5.13% is on the low side compared to the rest of the industry. DRW3 is outperformed by 63.79% of its industry peers.
DRW3's Operating Margin has improved in the last couple of years.
DRW3 has a worse Gross Margin (44.86%) than 67.24% of its industry peers.
In the last couple of years the Gross Margin of DRW3 has remained more or less at the same level.
Industry RankSector Rank
OM 5.13%
PM (TTM) 2.97%
GM 44.86%
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
DRW3.DE Yearly Profit, Operating, Gross MarginsDRW3.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

5

2. Health

2.1 Basic Checks

DRW3 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for DRW3 has been reduced compared to 1 year ago.
The number of shares outstanding for DRW3 has been increased compared to 5 years ago.
Compared to 1 year ago, DRW3 has an improved debt to assets ratio.
DRW3.DE Yearly Shares OutstandingDRW3.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
DRW3.DE Yearly Total Debt VS Total AssetsDRW3.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

DRW3 has an Altman-Z score of 2.66. This is not the best score and indicates that DRW3 is in the grey zone with still only limited risk for bankruptcy at the moment.
DRW3's Altman-Z score of 2.66 is in line compared to the rest of the industry. DRW3 outperforms 58.62% of its industry peers.
DRW3 has a debt to FCF ratio of 3.51. This is a good value and a sign of high solvency as DRW3 would need 3.51 years to pay back of all of its debts.
DRW3 has a Debt to FCF ratio of 3.51. This is in the better half of the industry: DRW3 outperforms 75.86% of its industry peers.
DRW3 has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.16, DRW3 is doing good in the industry, outperforming 74.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 3.51
Altman-Z 2.66
ROIC/WACC1.02
WACC6.4%
DRW3.DE Yearly LT Debt VS Equity VS FCFDRW3.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

DRW3 has a Current Ratio of 1.74. This is a normal value and indicates that DRW3 is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.74, DRW3 is in line with its industry, outperforming 51.72% of the companies in the same industry.
DRW3 has a Quick Ratio of 1.03. This is a normal value and indicates that DRW3 is financially healthy and should not expect problems in meeting its short term obligations.
DRW3 has a Quick ratio (1.03) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.03
DRW3.DE Yearly Current Assets VS Current LiabilitesDRW3.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

3

3. Growth

3.1 Past

DRW3 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.12%.
The Earnings Per Share has been growing by 36.42% on average over the past years. This is a very strong growth
The Revenue has decreased by -0.03% in the past year.
DRW3 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.92% yearly.
EPS 1Y (TTM)-14.12%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%-57.73%
Revenue 1Y (TTM)-0.03%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%-0.6%

3.2 Future

DRW3 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.39% yearly.
The Revenue is expected to grow by 2.84% on average over the next years.
EPS Next Y2.83%
EPS Next 2Y10.4%
EPS Next 3Y12.28%
EPS Next 5Y6.39%
Revenue Next Year3.31%
Revenue Next 2Y3.76%
Revenue Next 3Y3.9%
Revenue Next 5Y2.84%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DRW3.DE Yearly Revenue VS EstimatesDRW3.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B
DRW3.DE Yearly EPS VS EstimatesDRW3.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.61, which indicates a correct valuation of DRW3.
98.28% of the companies in the same industry are more expensive than DRW3, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.30, DRW3 is valued rather cheaply.
A Price/Forward Earnings ratio of 9.27 indicates a reasonable valuation of DRW3.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DRW3 indicates a rather cheap valuation: DRW3 is cheaper than 96.55% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.73, DRW3 is valued rather cheaply.
Industry RankSector Rank
PE 12.61
Fwd PE 9.27
DRW3.DE Price Earnings VS Forward Price EarningsDRW3.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DRW3 is valued cheaper than 91.38% of the companies in the same industry.
DRW3's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DRW3 is cheaper than 98.28% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.89
EV/EBITDA 4.54
DRW3.DE Per share dataDRW3.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
DRW3's earnings are expected to grow with 12.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.45
PEG (5Y)0.35
EPS Next 2Y10.4%
EPS Next 3Y12.28%

6

5. Dividend

5.1 Amount

DRW3 has a Yearly Dividend Yield of 3.46%.
Compared to an average industry Dividend Yield of 2.13, DRW3 pays a better dividend. On top of this DRW3 pays more dividend than 98.28% of the companies listed in the same industry.
DRW3's Dividend Yield is a higher than the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 3.46%

5.2 History

The dividend of DRW3 is nicely growing with an annual growth rate of 51.02%!
Dividend Growth(5Y)51.02%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DRW3 pays out 37.52% of its income as dividend. This is a sustainable payout ratio.
The dividend of DRW3 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP37.52%
EPS Next 2Y10.4%
EPS Next 3Y12.28%
DRW3.DE Yearly Income VS Free CF VS DividendDRW3.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M 300M
DRW3.DE Dividend Payout.DRW3.DE Dividend Payout, showing the Payout Ratio.DRW3.DE Dividend Payout.PayoutRetained Earnings

DRAEGERWERK AG - PREF

FRA:DRW3 (9/12/2025, 4:25:58 PM)

67.2

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-29 2025-07-29
Earnings (Next)10-29 2025-10-29
Inst Owners9.97%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.26B
Analysts77.14
Price Target89.05 (32.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.46%
Yearly Dividend1.77
Dividend Growth(5Y)51.02%
DP37.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.39%
PT rev (3m)2.91%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2%
EPS NY rev (3m)2%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.25%
Revenue NY rev (3m)-0.5%
Valuation
Industry RankSector Rank
PE 12.61
Fwd PE 9.27
P/S 0.38
P/FCF 9.89
P/OCF 6.61
P/B 0.86
P/tB 1.12
EV/EBITDA 4.54
EPS(TTM)5.33
EY7.93%
EPS(NY)7.25
Fwd EY10.78%
FCF(TTM)6.79
FCFY10.11%
OCF(TTM)10.16
OCFY15.12%
SpS179.14
BVpS78.08
TBVpS59.93
PEG (NY)4.45
PEG (5Y)0.35
Profitability
Industry RankSector Rank
ROA 3.34%
ROE 6.82%
ROCE 8.71%
ROIC 6.55%
ROICexc 7.37%
ROICexgc 9.14%
OM 5.13%
PM (TTM) 2.97%
GM 44.86%
FCFM 3.79%
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-18.01%
ROICexcg growth 5Y12.44%
ROICexc growth 3Y-16.98%
ROICexc growth 5Y13.06%
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
F-Score6
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 3.51
Debt/EBITDA 0.73
Cap/Depr 43.12%
Cap/Sales 1.88%
Interest Coverage 9.3
Cash Conversion 59.79%
Profit Quality 127.61%
Current Ratio 1.74
Quick Ratio 1.03
Altman-Z 2.66
F-Score6
WACC6.4%
ROIC/WACC1.02
Cap/Depr(3y)46.64%
Cap/Depr(5y)59.31%
Cap/Sales(3y)2.11%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.12%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%-57.73%
EPS Next Y2.83%
EPS Next 2Y10.4%
EPS Next 3Y12.28%
EPS Next 5Y6.39%
Revenue 1Y (TTM)-0.03%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%-0.6%
Revenue Next Year3.31%
Revenue Next 2Y3.76%
Revenue Next 3Y3.9%
Revenue Next 5Y2.84%
EBIT growth 1Y-8.68%
EBIT growth 3Y-13.63%
EBIT growth 5Y16.27%
EBIT Next Year81.53%
EBIT Next 3Y29.41%
EBIT Next 5Y12.32%
FCF growth 1Y1126.25%
FCF growth 3Y-27.65%
FCF growth 5Y0.28%
OCF growth 1Y201.26%
OCF growth 3Y-24.25%
OCF growth 5Y0.35%